本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Envista Holdings

21.53
+0.76003.66%
成交量:86.04万
成交额:1,843.74万
市值:35.78亿
市盈率:69.03
高:21.63
开:20.96
低:20.69
收:20.77
52周最高:23.00
52周最低:14.22
股本:1.66亿
流通股本:1.66亿
量比:0.54
换手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):0.3119
每股收益(LYR):-6.4959
净资产收益率:1.76%
总资产收益率:2.20%
市净率:1.14
市盈率(LYR):-3.31

数据加载中...

公司资料

公司名字:
Envista Holdings
交易所:
NYSE
成立时间:
2018
员工人数:
12300
公司地址:
Building E,200 South Kraemer Boulevard,Brea,California,United States
邮编:
92821-6208
电话:
传真:
714-817-5450
简介:
Envista Holdings Corporation于2018年8月29日在特拉华州注册成立。Envista是全球最大的牙科产品公司之一,在牙科产品行业的一些最具吸引力的领域拥有重要的市场地位,包括植入物,口腔正畸和数字成像技术。

董事

名称
职位
Paul A. Keel
Director, President and Chief Executive Officer
Richard Scott Huennekens
Chairman of the Board
Barbara B. Hulit
Independent Director
Christine A. Tsingos
Independent Director
Daniel A. Raskas
Independent Director
Kieran T. Gallahue
Independent Director
Vivek Jain
Independent Director
Wendy Carruthers
Independent Director
J. Andrew Pierce
Director

股东

名称
职位
Paul A. Keel
Director, President and Chief Executive Officer
Eric D. Hammes
Senior Vice President and Chief Financial Officer
Mark E. Nance
Senior Vice President, General Counsel and Secretary
Mischa M. Reis
Senior Vice President, Strategy and Corporate Development
Faez C. Kaabi
Vice President and Chief Accounting Officer
Robert Befidi
President, Diagnostics
Stefan Nilsson
President, Nobel Biocare
Veronica Acurio
President, Orthodontics